Rachael Kimber is a dedicated Immunologist with over six years of industry experience specializing in the development of cancer therapeutics.

She recently received her PhD in Biological Sciences from the University of Cambridge in association with the Babraham Institute, furthering her expertise in Immunology and RNA biology.